OKYO Pharma Limited

OKYO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.35

+$0.02 (+1.50%)

At close: Sep 22, 2026, 4:00 PM ET

$1.33

-$0.02 (-1.48%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $51.03M

Enterprise Value $30.43M

Beta 0.05

Average Volume 85.52K

Shares Outstanding (Diluted) 52.48M

Shares Change YoY 59.16%

Institutional Ownership N/A

Exchange NASDAQ

ISIN GG00BMFG5F62

Price Performance

Price Change 1M -13.6%

Price Change 3M -15.8%

Price Change 6M -15.8%

Price Change YTD -40.4%

Price Change 1Y -40.9%

Price Change 3Y -33.0%

Price Change 5Y -55.7%

1M CAGR (ann.) -10.7%

1Y CAGR (ann.) -35.8%

5Y CAGR (ann.) N/A

All-Time CAGR -20.6%

Valuation

PE Ratio -7.00

Forward PE N/A

PEG Ratio 0.05

Forward PEG -0.03

PS Ratio N/A

Forward PS N/A

PB Ratio 4.14

P/FCF Ratio -8.59

P/Adj. FCF Ratio -8.59

P/OCF Ratio -8.31

EV/Sales N/A

EV/EBIT -3.31

EV/EBITDA -3.31

EV/FCF -5.12

Earnings Yield -14.3%

FCF Yield -11.6%

Adj. FCF Yield -11.6%

Financial Health

Net Cash $20.59M

Total Debt $0

Cash & Short-Term Investments $20.59M

Total Assets $20.98M

Current Ratio 2.43

Quick Ratio 2.43

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -20.81

Altman Z-Score -7.34

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -42.7%

Return on Equity -200.7%

Return on Invested Capital -74.6%

Return on Capital Employed -74.6%

Return on Tangible Assets -42.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 46.3%

EPS CAGR 5Y -14.3%

EPS CAGR 10Y 27.3%

FCF CAGR 3Y -4.3%

FCF CAGR 5Y -41.5%

FCF CAGR 10Y -17.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y -70.2%

Revenue Growth Next 3Y N/A

Earnings Date Dec 1, 2026

EPS Estimate (next Q) -$0.06

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5

Price Target Upside 275.9%

Cash Flow

Operating Cash Flow $-5.94M

Free Cash Flow $-5.94M

Adj. Free Cash Flow $-5.94M

FCF Per Share -$0.16

OCF Per Share -$0.16

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-1.82K

Operating Income $-9.2M

EBITDA $-9.2M

Net Income $-8.95M

EPS (Diluted) -$0.19

Revenue / Employee N/A

Profit / Employee $-1.79M

Employees 5